News News Select Year All Years 2026 (30) 2025 (34) 2024 (29) 2023 (30) 2022 (33) 2021 (27) 2020 (34) 2019 (32) 2018 (42) 2017 (35) 2016 (43) 2015 (53) 2014 (26) 2013 (21) 2012 (16) 2011 (6) 2010 (4) 2009 (5) 2007 (1) 2006 (1) Search News Found 502 Results Page 49 of 51« First«...102030...4748495051» May 15, 2012 First quarter 2012 topline, scientific activity and upcoming clinical data May 10, 2012 DBV Technologies welcomes Charles Ruban as Chief Development Officer March 28, 2012 Successful Initial Public Offering (IPO) for DBV Technologies February 28, 2012 Viaskin Peanut receives FDA “Fast Track Designation” January 31, 2012 DBV Technologies announces the filing of its “Document de Base” with the French Autorité des marchés financiers December 6, 2011 DBV Technologies introduces its new Chief Financial Officer September 21, 2011 DBV Technologies moves to Bagneux June 8, 2011 DBV Technologies VIASKIN® technology has been chosen to feature on the cover of the European Journal of Allergy and Clinical Immunology June 2011 issue in its timeline “100 years allergen specific immunotherapy.” January 18, 2011 DBV Technologies elects George Horner as non executive Chairman January 8, 2011 DBV Technologies is very proud to have been chosen to feature on the cover of the Journal of Allergy and Clinical Immunology January 2011 issue Page 49 of 51« First«...102030...4748495051»